Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.8419
-0.0038 (-0.45%)
At close: Dec 5, 2025, 4:00 PM EST
0.8401
-0.0018 (-0.21%)
After-hours: Dec 5, 2025, 7:46 PM EST
Envoy Medical Stock Forecast
COCH's stock price has decreased by -59.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Envoy Medical stock has a target of 9.50, which predicts a 1,028.40% increase from the current stock price of 0.84.
Price Target: $9.50 (+1,028.40%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Envoy Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9.25 → $9.5 | Strong Buy | Maintains | $9.25 → $9.5 | +1,028.40% | May 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $9.25 | Strong Buy | Maintains | $9 → $9.25 | +998.71% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.75 → $9 | Strong Buy | Maintains | $8.75 → $9 | +969.01% | Dec 6, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +969.01% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +939.32% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
196.86K
from 225.00K
Decreased by -12.51%
Revenue Next Year
255.00K
from 196.86K
Increased by 29.53%
EPS This Year
-1.19
from -1.49
EPS Next Year
-1.20
from -1.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 210,000 | 315,000 |
| Avg | 196,860 | 255,000 |
| Low | 182,280 | 196,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -6.7% | 60.0% |
| Avg | -12.5% | 29.5% |
| Low | -19.0% | -0.4% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.19 | -1.24 |
| Avg | -1.19 | -1.20 |
| Low | -1.19 | -1.16 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.